| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D Hughes, M Morco. Use of Aripiprazole in treatment resistant schizophrenia. Journal of psychopharmacology (Oxford, England). vol 22. issue 8. 2009-01-13. PMID:18308805. |
use of aripiprazole in treatment resistant schizophrenia. |
2009-01-13 |
2023-08-12 |
Not clear |
| D Hughes, M Morco. Use of Aripiprazole in treatment resistant schizophrenia. Journal of psychopharmacology (Oxford, England). vol 22. issue 8. 2009-01-13. PMID:18308805. |
the findings from this case series suggest that there is scope for a trial of aripiprazole for patients with treatment resistant schizophrenia and an invitation for further research of this area. |
2009-01-13 |
2023-08-12 |
Not clear |
| Herbert Y Meltzer, Tomiki Sumiyosh. Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Behavioural brain research. vol 195. issue 1. 2009-01-12. PMID:18707769. |
aripiprazole, clozapine, olanzapine, perospirone, quetiapine risperidone, and ziprasidone are examples of atypical antipsychotic drugs which are either direct or indirect 5-ht(1a) agonists which have been shown to improve cognitive function in patients with schizophrenia. |
2009-01-12 |
2023-08-12 |
Not clear |
| John M Kane, Sheila Assunção-Talbott, James M Eudicone, Andrei Pikalov, Richard Whitehead, David T Crandal. The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials. Schizophrenia research. vol 105. issue 1-3. 2008-12-11. PMID:18790605. |
the efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials. |
2008-12-11 |
2023-08-12 |
Not clear |
| John M Kane, Sheila Assunção-Talbott, James M Eudicone, Andrei Pikalov, Richard Whitehead, David T Crandal. The efficacy of aripiprazole in the treatment of multiple symptom domains in patients with acute schizophrenia: a pooled analysis of data from the pivotal trials. Schizophrenia research. vol 105. issue 1-3. 2008-12-11. PMID:18790605. |
to examine the efficacy of aripiprazole across symptoms in patients with acute exacerbation of schizophrenia or schizoaffective disorder. |
2008-12-11 |
2023-08-12 |
Not clear |
| De-zhi Zeng, Jian-wu Luo, Xue-wen Fa. [Clinical observation on effect of Jieyu Anshen Decoction combined with aripiprazole in treating chronic schizophrenia]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. vol 27. issue 4. 2008-12-10. PMID:17526180. |
[clinical observation on effect of jieyu anshen decoction combined with aripiprazole in treating chronic schizophrenia]. |
2008-12-10 |
2023-08-12 |
Not clear |
| De-zhi Zeng, Jian-wu Luo, Xue-wen Fa. [Clinical observation on effect of Jieyu Anshen Decoction combined with aripiprazole in treating chronic schizophrenia]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. vol 27. issue 4. 2008-12-10. PMID:17526180. |
to explore the efficacy and safety of jieyu anshen decoction (jad) combined with aripiprazole in treating chronic schizophrenia. |
2008-12-10 |
2023-08-12 |
Not clear |
| David W Boulton, Georgia Kollia, Suresh Mallikaarjun, Bernard Komoroski, Anjali Sharma, Lawrence J Kovalick, Richard A Reeve. Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia. Clinical pharmacokinetics. vol 47. issue 7. 2008-12-08. PMID:18563956. |
pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia. |
2008-12-08 |
2023-08-12 |
human |
| David W Boulton, Georgia Kollia, Suresh Mallikaarjun, Bernard Komoroski, Anjali Sharma, Lawrence J Kovalick, Richard A Reeve. Pharmacokinetics and tolerability of intramuscular, oral and intravenous aripiprazole in healthy subjects and in patients with schizophrenia. Clinical pharmacokinetics. vol 47. issue 7. 2008-12-08. PMID:18563956. |
the efficacy and tolerability of intramuscular aripiprazole injection has been established in agitated inpatients with schizophrenia or bipolar i disorder. |
2008-12-08 |
2023-08-12 |
human |
| Christian J Bachmann, Anette Rieger-Gies, Monika Heinzel-Gutenbrunner, Christoph Hiemke, Helmut Remschmidt, Frank M Theise. Large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia. Therapeutic drug monitoring. vol 30. issue 4. 2008-12-08. PMID:18641558. |
large variability of aripiprazole and dehydroaripiprazole serum concentrations in adolescent patients with schizophrenia. |
2008-12-08 |
2023-08-12 |
Not clear |
| Gunnar Sørensen, Thomas N Sager, Jørgen H Petersen, Lise T Brennum, Peter Thøgersen, Cecilie Hee Bengtsen, Morgane Thomsen, Gitta Wörtwein, Anders Fink-Jensen, David P D Woldby. Aripiprazole blocks acute self-administration of cocaine and is not self-administered in mice. Psychopharmacology. vol 199. issue 1. 2008-12-03. PMID:18481046. |
the novel antipsychotic aripiprazole in use for treatment of schizophrenia is a partial agonist at dopamine d2 receptors with actions at a variety of other receptors as well. |
2008-12-03 |
2023-08-12 |
mouse |
| Hiroyoshi Takeuchi, Takefumi Suzuki, Hiroyuki Uchida, Shinichiro Nakajima, Kensuke Nomura, Toshiaki Kikuchi, Hiroshi Manki, Koichiro Watanabe, Haruo Kashim. A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering. Journal of clinical psychopharmacology. vol 28. issue 5. 2008-11-24. PMID:18794650. |
a randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering. |
2008-11-24 |
2023-08-12 |
human |
| Hiroyoshi Takeuchi, Takefumi Suzuki, Hiroyuki Uchida, Shinichiro Nakajima, Kensuke Nomura, Toshiaki Kikuchi, Hiroshi Manki, Koichiro Watanabe, Haruo Kashim. A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering. Journal of clinical psychopharmacology. vol 28. issue 5. 2008-11-24. PMID:18794650. |
although recent treatment guidelines for schizophrenia recommend that the prior antipsychotic agent should remain stable for at least 2 weeks when aripiprazole is introduced, there is no trial-based evidence to support this strategy. |
2008-11-24 |
2023-08-12 |
human |
| Hiroyoshi Takeuchi, Takefumi Suzuki, Hiroyuki Uchida, Shinichiro Nakajima, Kensuke Nomura, Toshiaki Kikuchi, Hiroshi Manki, Koichiro Watanabe, Haruo Kashim. A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering. Journal of clinical psychopharmacology. vol 28. issue 5. 2008-11-24. PMID:18794650. |
we conducted a randomized, 14-week, open-label trial to compare the following 2 switching strategies: (1) add-on of aripiprazole on a current regimen, wait for 4 weeks, and the tapering of prior antipsychotics and (2) add-on of aripiprazole and the simultaneous tapering of prior antipsychotics in patients with schizophrenia. |
2008-11-24 |
2023-08-12 |
human |
| David Taylor, Linda Hanssens, Jean-Yves Loze, Miranda Pans, Gilbert L'Italien, Ronald N Marcu. Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: results from the STAR study. European psychiatry : the journal of the Association of European Psychiatrists. vol 23. issue 5. 2008-11-18. PMID:18423987. |
to evaluate quality of life and patient preference for schizophrenia treatment in a community based study comparing the use of aripiprazole to the standard of care (soc). |
2008-11-18 |
2023-08-12 |
Not clear |
| Robert L Findling, Adelaide Robb, Margaretta Nyilas, Robert A Forbes, Na Jin, Svetlana Ivanova, Ronald Marcus, Robert D McQuade, Taro Iwamoto, William H Carso. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. The American journal of psychiatry. vol 165. issue 11. 2008-11-18. PMID:18765484. |
a multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. |
2008-11-18 |
2023-08-12 |
Not clear |
| Robert L Findling, Adelaide Robb, Margaretta Nyilas, Robert A Forbes, Na Jin, Svetlana Ivanova, Ronald Marcus, Robert D McQuade, Taro Iwamoto, William H Carso. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. The American journal of psychiatry. vol 165. issue 11. 2008-11-18. PMID:18765484. |
aripiprazole is a dopamine partial agonist approved for use in adults for short- and long-term treatment of schizophrenia and bipolar disorder. |
2008-11-18 |
2023-08-12 |
Not clear |
| Robert L Findling, Adelaide Robb, Margaretta Nyilas, Robert A Forbes, Na Jin, Svetlana Ivanova, Ronald Marcus, Robert D McQuade, Taro Iwamoto, William H Carso. A multiple-center, randomized, double-blind, placebo-controlled study of oral aripiprazole for treatment of adolescents with schizophrenia. The American journal of psychiatry. vol 165. issue 11. 2008-11-18. PMID:18765484. |
this study was designed to examine the acute efficacy, safety, and tolerability of aripiprazole for adolescents with schizophrenia. |
2008-11-18 |
2023-08-12 |
Not clear |
| Jayanti Bhattacharjee, Hany George G El-Saye. Aripiprazole versus typical antipsychotic drugs for schizophrenia. The Cochrane database of systematic reviews. issue 3. 2008-10-15. PMID:18646161. |
aripiprazole versus typical antipsychotic drugs for schizophrenia. |
2008-10-15 |
2023-08-12 |
Not clear |
| Mark Sanford, Gillian M Keatin. Aripiprazole in adolescents with schizophrenia: profile report. CNS drugs. vol 22. issue 6. 2008-09-24. PMID:18484794. |
aripiprazole in adolescents with schizophrenia: profile report. |
2008-09-24 |
2023-08-12 |
Not clear |